|
RPTX Repare Therapeutics Inc 1808158 |
| Balance Sheet |
|
Current Assets
|
171,149,000 |
|
Assets
|
176,506,000 |
|
Current Liabilities
|
25,287,000 |
|
Liabilities
|
25,375,000 |
|
Equity
|
151,131,000 |
|
Shares Out
|
42,446,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-76,445,000 |
|
Investing Cash Flow
|
49,468,000 |
| Market Analysis |
Market Cap
|
138,372,394 |
|
Price
|
1.15 |
|
BVPS
|
3.56 |
|
PB
|
0.32 |
|
EPS
|
-1.63 |
|
PS
|
18.36 |
|
FCF
|
-26,977,000 |
|
| Earnings |
|
| Jan |
Feb |
Mar |
|
|
2/28 |
-0.67 |
3/3 |
-2.00 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view RPTX documents filed with the SEC.
RPTX Filings
Clear
